SEROEPIDEMIOLOGY AND SERODIAGNOSIS OF SCHISTOSOMIASIS AT PASTEUR INSTITUTE OF COTE D

K.E. ANGORA¹, A.T. OFFIANAN²*, W. YAVO³, V. DJOHAN⁴, A.H. VANGA-BOSSON⁵, A. IRA-BONOUMAN⁶, A. KONATE⁷, K.F. KASSI⁸, G.S. DOU⁹, P.C. KIKI-BARRO¹⁰, E.I.H. MENAN^11
1Parasitology and Mycology Department UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Cote dIvoire; Parasitology and Mycology Department, Institute Pasteur of Cote dIvoire
²Parasitology and Mycology Department, Institute Pasteur of Cote dIvoire
³Parasitology and Mycology Department UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Cote dIvoire
⁴Parasitology and Mycology Department UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Cote dIvoire
⁵Parasitology and Mycology Department UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Cote dIvoire; Parasitology and Mycology Department, Institute Pasteur of Cote dIvoire
⁶Parasitology and Mycology Department, Institute Pasteur of Cote dIvoire
⁷Parasitology and Mycology Department UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Cote dIvoire
⁸Parasitology and Mycology Department UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Cote dIvoire; Centre de Diagnostic et de Recherche sur le SIDA et les maladies opportunistes, Abidjan, Cote dIvoire
⁹Parasitology and Mycology Department, UFR Sciences Medicales, Abidjan, Cote dIvoire
¹⁰Parasitology and Mycology Department UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Cote dIvoire
¹¹Parasitology and Mycology Department UFR des Sciences Pharmaceutiques et Biologiques, Abidjan, Cote dIvoire; Centre de Diagnostic et de Recherche sur le SIDA et les maladies opportunistes, Abidjan, Cote dIvoire
* Corresponding Author : andretoure@pasteur.ci

Received : 28-10-2015     Accepted : 02-12-2015     Published : 15-12-2015
Volume : 7     Issue : 2       Pages : 164 - 167
Int J Parasitol Res 7.2 (2015):164-167

Keywords : Schistosomiasis, Diagnosis, Antibody-detection, Institut Pasteur Cote dIvoire
Academic Editor : Hudson A. Pinto, Ting-bao Yang, Ting-bao Yang, Natalia Fraija-fernandez, Thales Domingos Arantes, C. C. Bassetto, E. Sherrard-smith, Daniel Aguirre-ayala, J. Petrasova, A. L. Barashkova, Francisco Rogerlandio Martins-melo, Maria Angeles Gomez-morales, Carlos Landaeta-aqueveque, Silmara Marques Allegretti
Conflict of Interest : The authors have no conflicts of interest concerning the work reported in this paper.
Acknowledgements/Funding : Financial support of this study was provided par Institut Pasteur of Cote dIvoire. We are grateful to the Department of Parasitology Mycology for his support for conducting this work. Special thanks to all patients who participated in this study. We are grateful to the Director, Institut Pasteur of Cote dIvoire, for his kind permission to publish the data.
Author Contribution : None declared

Objectives: Schistosomiasis is a major parasitic disease affecting more than 200 million people in the developing world, and 400 million people are at risk for infection. The main objective of the study was to assess the prevalence of schistosomiasis through a serological method in a reference laboratory in Côte d’Ivoire. This retrospective study was conducted using laboratory data obtained from 2006 to 2014 at the Parasitology Unit of Institute Pasteur of Côte d’Ivoire. The serological routine method was the indirect hemagglutination assays schistosomiasis kit from Fumouze Laboratories (Levallois-Perret, France). Sociodemographic and clinical indications for the diagnosis of schistosomiasis were collected using a database of laboratory records spanning 2006 to 2014. Any difference in the prevalence of infections among different sexes or age groups were interpreted statistically. A total of 502 patients were attended Parasitology Unit from 2006 to 2014 for a serological diagnosis of schistosomiasis. The sex ratio was 1.9 male to female with a mean age of 35.1 years [3-85 years]. Prevalence of schistosomiasis was 23.3%, however, no statistically significant difference was observed according to age or sex (p> 0.05). High seroprevalence was observed in 2012 (45.7%) following by 2007 (42.9%) and less prevalence was observed in 2009 (3.6%). The seroprevalence of Schistosoma infection was found to be relatively high among the study population suggesting major interventions to reduce the burden of this disease in the country.